DYNACERT INC. WKN: A1KBAV ISIN: CA26780A1084 Kürzel: DMJ Forum: Aktien Thema: Hauptdiskussion
im financial statement vom juni heisst es .. On July 31, 2023, the Company provided an update to it's press release that was issued on May 26, 2023, regarding a a purchase order of 3,000 Units. The Company has now been obliged to delay the delivery of all but two such HydraGEN™ Units. The Company is awaiting information from a representative which is necessary for the final packaging and shipping of the HydraGEN™ Units. The Company has also been advised by a representative that the two HydraGEN™ Units that were delivered might still be awaiting clearing from Guyanese customs by an agent of the Purchaser. Issues regarding the transfer of payments from Guyana for the HydraGEN™ Units that were ordered are also pending. Deliveries of HydraGEN™ Units in this purchase order are postponed pending further notice by either the Purchaser or the broker, acting as a conduit, until the outstanding issues have been resolved.
Mehr zu diesem Wert
|
Thema | ||
---|---|---|---|
1 | DYNACERT INC. Hauptdiskussion | ||
2 | DYNACERT NEWS |
|
Thema | ||
---|---|---|---|
1 | ATOS Hauptdiskussion | +130,65 % | |
2 | Spineway Act Hauptdiskussion | +77,71 % | |
3 | NVIDIA Hauptdiskussion | -2,38 % | |
4 | Europlasma Hauptdiskussion | +323,13 % | |
5 | COVESTRO AG O.N. Hauptdiskussion | -0,19 % | |
6 | BTC/USD Hauptdiskussion | +5,51 % | |
7 | GAMESTOP Hauptdiskussion | +3,22 % | |
8 | MicroStrategy | +6,81 % | |
9 | Verastem | +12,53 % | |
10 | Trading- und Aktien-Chat | Alle Diskussionen |
|
Thema | ||
---|---|---|---|
1 | ATOS Hauptdiskussion | +140,32 % | |
2 | Spineway Act Hauptdiskussion | +62,65 % | |
3 | NVIDIA Hauptdiskussion | -2,32 % | |
4 | Europlasma Hauptdiskussion | +323,13 % | |
5 | COVESTRO AG O.N. Hauptdiskussion | -0,19 % | |
6 | GAMESTOP Hauptdiskussion | +3,07 % | |
7 | MicroStrategy | +6,98 % | |
8 | Verastem | +12,53 % | |
9 | CYTOMX THERAPEUTICS INC. Hauptdiskussion | -1,94 % | |
10 | MICROSTRATEGY Hauptdiskussion | +6,98 % | Alle Diskussionen |